GlassScriptPhysician profile
Wissam Gharib
NPI 1386757037
$178,736.44
in general payments reported to CMS, 2019-2025
45 companies · $36K in 2025
The $36K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $35K · 2021: $16K · 2022: $11K · 2023: $35K · 2024: $14K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $20K · Travel and Lodging: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,750.00 |
| Food and Beverage | $19,564.88 |
| Travel and Lodging | $12,177.17 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $97,135.63 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Recor Medical INC | $14,287.59 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Shockwave Medical, INC | $13,246.00 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Edwards Lifesciences Corporation | $11,972.40 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bard Peripheral Vascular, INC. | $8,575.85 | 2019-2021 | |
| Biotronik INC. | $7,154.59 | 2019-2025 | Orsiro Mission, Pk Papyrus |
| Abbott Laboratories | $6,974.09 | 2019-2025 | Amplatzer Amulet, Diamondback Coronary, Cardiomems |
| Medtronic, INC. | $4,416.88 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Endurant Iis |
| Philips North America LLC | $2,795.80 | 2019-2022 | |
| Terumo Medical Corporation | $1,795.74 | 2019-2024 | Heartrail, R2p Misago |
| Abiomed | $1,328.90 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $975.04 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $775.86 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $757.77 | 2019-2023 | Diamondback Coronary |
| Amgen INC. | $713.83 | 2019-2024 | Repatha |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $582.50 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $582.44 | 2023-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $562.58 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $464.83 | 2019-2024 | Farxiga, Brilinta, Wainua |
| Medtronic Vascular, INC. | $440.75 | 2019-2020 | |
| Penumbra, INC. | $408.77 | 2025 | Indigo System, Penumbra System |
| E.R. Squibb & Sons, L.L.C. | $375.10 | 2019-2024 | Camzyos, Eliquis |
| Heartflow, INC. | $316.04 | 2022-2025 | Ffrct |
| Vital Connect, INC | $255.66 | 2022-2023 | Vitalpatch Rtm |
| Siemens Medical Solutions USA, INC. | $248.07 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System, Artis Pheno |
| Teleflex LLC | $186.00 | 2019-2025 | Orsiro Mission |
| Cordis US Corp. | $150.00 | 2022 | |
| Stryker Corporation | $126.49 | 2025 | Artix Mt, Flowtriever |
| Merck Sharp & Dohme LLC | $121.29 | 2022-2024 | Verquvo |
| Novo Nordisk INC | $113.17 | 2023-2025 | Wegovy, Ozempic |
| Journey Medical Corporation | $111.66 | 2024 | |
| Veryan Medical Incorporated | $109.18 | 2021 | |
| Janssen Scientific Affairs, LLC | $99.56 | 2024 | Xarelto |
| Osprey Medical INC | $88.61 | 2020 | |
| Cvrx, INC. | $78.79 | 2024 | Barostim Neo System |
| Canon Medical Systems USA, INC. | $74.52 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $66.17 | 2023 | Inpefa |
| Angiodynamics, INC. | $63.12 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $57.98 | 2019-2024 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $41.44 | 2024 | Arcalyst |
| Pfizer INC. | $33.05 | 2022-2024 | |
| Gilead Sciences, INC. | $26.76 | 2019 | |
| Atricure, INC. | $18.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.41 | 2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $12.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wissam Gharib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.